Drugmaker Bristol-Myers Squibb said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash, aiming to diversify from legacy products facing ...
Bristol Myers Squibb has agreed to buy privately held biotechnology company Orbital Therapeutics for $1.5 billion in cash in a deal that bolsters the drugmaker's cell-therapy portfolio. Bristol Myers ...
IoCDB Share project repository, a CTI platform that collects data from VirusTotal, AlienVault OTX, PolySwarm and AbuseIPDB APIs for hashes, domains and IPs. AegisFlow is a threat-aware CI/CD pipeline ...
OTX Boxing Atlanta delivered a spectacular return to the city as OTX 15 electrified The Tabernacle on July 25. This highly anticipated event wasn’t just another night of fights; it was a demonstration ...
Atlanta, GA (July 1, 2025) Overtime Boxing (OTX), The Platform for the Next Generation of Boxers, returns to Atlanta, GA on Friday, July 25 with a stellar eight-fight card at Tabernacle headlined by a ...
The advantage of open-source network security software is that it’s free and flexible for any customization. Some of the tools provide network identification and threat detection while others help you ...
Results from a phase 2 study of triplet blockade of the IL-27, PD-(L)1, and VEGF pathways with casdozokitug (casdozo, CHS-388) in combination with atezolizumab and bevacizumab in patients with ...
Please provide your email address to receive an email when new articles are posted on . Seventy-three percent of patients treated with OTX-TKI were rescue-free up to 40 weeks. OTX-TKI led to an 89% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results